Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations

Chondrosarcoma (CS) is a rare tumour type and the most common primary malignant bone cancer in adults. The prognosis, currently based on tumour grade, imaging and anatomical location, is not reliable, and more objective biomarkers are required. We aimed to determine whether the level of circulating...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Iben Lyskjær, Christopher Davies, Anna‐Christina Strobl, Joanna Hindley, Steven James, Radhesh K. Lalam, William Cross, Geoff Hide, Kenneth S. Rankin, Lee Jeys, Roberto Tirabosco, Jonathan Stevenson, Genomics England Research Consortium, Paul O’Donnell, Paul Cool, Adrienne M. Flanagan
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2021-12-01
Saila:	Molecular Oncology
Gaiak:	chondrosarcoma circulating tumour DNA GNAS IDH1 IDH2 prognosis
Sarrera elektronikoa:	https://doi.org/10.1002/1878-0261.13102
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!